Back to Search
Start Over
Allylphenols as a new class of human 15‐lipoxygenase‐1 inhibitors
- Source :
- Drug Development Research. 82:259-266
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- In this study, a series of mono- and diallylphenol derivative were designed, synthesized, and evaluated as potential human 15-lipoxygenase-1 (15-hLOX-1) inhibitors. Radical scavenging potency of the synthetic allylphenol derivatives was assessed and the results were in accordance with lipoxygenase (LOX) inhibition potency. It was found that the electronic natures of allyl moiety and para substituents play the main role in radical scavenging activity and subsequently LOX inhibition potency of the synthetic inhibitors. Among the synthetic compounds, 2,6-diallyl-4-(hexyloxy)phenol (42) and 2,6-diallyl-4-aminophenol (47) showed the best results for LOX inhibition (IC50 = 0.88 and 0.80 μM, respectively).
- Subjects :
- Dose-Response Relationship, Drug
biology
Stereochemistry
DPPH
Claisen rearrangement
03 medical and health sciences
chemistry.chemical_compound
Lipoxygenase
0302 clinical medicine
Phenols
chemistry
030220 oncology & carcinogenesis
Drug Discovery
biology.protein
Arachidonate 15-Lipoxygenase
Humans
Phenol
Moiety
Potency
Lipoxygenase Inhibitors
IC50
Cells, Cultured
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 10982299 and 02724391
- Volume :
- 82
- Database :
- OpenAIRE
- Journal :
- Drug Development Research
- Accession number :
- edsair.doi.dedup.....90ee400f01d09e16b36af10cc50acd03
- Full Text :
- https://doi.org/10.1002/ddr.21749